Humankind is currently confronting a new type of coronavirus, and it may take considerable time before the human population and the virus arrive at a mutual equilibrium. The first patients with coronavirus disease 2019 (COVID-19) were recorded in December 2019 in China (Zhu et al. 2020), and since then the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread globally. Other reputed members of the coronavirus family are SARS-CoV-1 and MERS-CoV, which caused zoonotic events that resulted in epidemics in 2002 and 2012, respectively (Peiris et al. 2003; Zaki et al. 2012). According to the WHO (22/4/2020), more than 2,400,000 individuals have been infected by SARS-CoV-2, and at least 165,000 have succumbed to the disease (https://covid19.who.int). Most patients with COVID-19 suffer from severe respiratory problems, and elderly people in particular or persons with comorbidities seem to be at greatest risk (Wang et al. 2020). The fatality rates for males are two to three times higher than for females (Porcheddu et al. 2020), but seem to fluctuate depending on the territory and demography of the population. Gender-related social factors, immunological differences, hormonal disparaties, and lifestyle habits such as smoking and alcohol consumption are considered to play a role (Wenham et al. 2020). The vulnerability of the male population with regard to the COVID-19 pandemic may to some extent be a result of gender-defined genetic polymorphisms.
At least two coronaviruses use Angiotensin Converting Enzyme 2 as port of entry (ACE-2) to infect the host (Hoffmann et al. 2020; Kuba et al. 2005). ACE2 plays an important role in controlling blood pressure and regulating cardiac function, and is abundantly present on the epithelial cells of the lung, heart, blood vessels, kidneys, and intestines. Although the gene for ACE2 is located on the female sex chromosome, its location and polymorphisms do not seem to have had a bearing on the poor prognosis for male patients during the SARS-CoV-1 epidemic (Chiu et al. 2004).
Another group of promising candidates could be genes involved in immunity. One of the prominent families that senses infection, and that is essential to the innate immune system, comprises the Toll-like receptors (TLR) (Akira and Takeda 2004). In humans, there are 10 different members, and each of them can be activated by different types of ligands stemming from disparate pathogens. TLR often act in the form of homo- or heterodimers, and play a role in clearing infections. Some TLR types are expressed on the cell surface, but the ones present on intracellular membranes of endosomes (TLR3, 7, 8, and 9) are intended to register, though not exclusively, viral infections by detecting foreign types of nucleic acids (Fitzgerald and Kagan 2020). The nuclear material of coronaviruses is single-stranded RNA (ssRNA). TLR3 and 9 interact with double-stranded viral RNA and unmethylated CpG DNA from bacteria and viruses, respectively (Parker et al. 2007). TLR3 may respond to infections by the West Nile virus – also an ssRNA virus – in a rodent model (Wang et al. 2004). In contrast to TLR3 and 9, the structurally related TLR7 and 8 tandem is encoded by the female X chromosome (Armant and Fenton 2002). Therefore, these latter two genes may represent gender-related risk factors. The prominent ligand for TLR7 and 8 is viral ssRNA (Diebold et al. 2004; Heil et al. 2004) and, more specifically for TLR8, its RNAse T2 degredation products (Greulich et al. 2019). In humans, TLR7 is constitutively expressed on the membranes of endosomes in plasmacytoid dendritic cells (DC) and B lymphocytes, whereas TLR8 is more prominently present in cells of the myeloid lineage such as monocytes and neutrophils (Hornung et al. 2002). TLR7-positive plamacytoid cells are copiously present in lung tissue (Plantinga et al. 2010). Upon activation of the TLR7 pathway, for instance by the influenza virus, plasmacytoid DC have the capacity to produce significant amounts of type I interferon (Di Domizio et al. 2009). Moreover, TLR8 is present in the lung, and is known to act upon infection by various viruses (Beignon et al. 2005; Heil et al. 2004). An immune response activated via the TLR7 and/or 8 pathway may also induce unwanted side effects. SARS-Cov-1, for instance, may induce a cytokine storm (Tang et al. 2016), and the viral activation of neutrophils in the case of asthma may result in lung pathology (Li et al. 2013). One of the two female sex chromosomes is generally inactivated in females (Lyon 1992; Schurz et al. 2019). In female immune cells, however, TLR7 genes – and probably TLR8 – escape such silencing. As a consequence, the genetic information on both chromosomes is expressed, whereas male individuals possess only a single copy of the X chromosome (Souyris et al. 2018). Gender-related expression profiles may result in a prominent dosage effect in which females are more prone to activate an immune response to single-stranded viruses such as SARS-CoV-2. Furthermore, the induction of cytokine profiles seems also to be dose dependent on the amount of genetic material delivered by the virus (Tang et al. 2016).
This gender-determined dosage effect, however, is probably not the whole story. The TLR7 and 8 genes display copy number variation (CNV) in the population (Wang et al. 2014). In addition, TLR genes display allelic polymorphisms (Menendez et al. 2019; Wang et al. 2014) that may influence the strength of the interaction with their respective ligands or the quality of the ensuing signal that is transduced to the nucleus. There is ample proof that gender-based CNV of TLR7 has medical implications. The best-documented example is provided by systemic lupus erythematosus (SLE), a disorder in which the immune system attacks healthy tissue. This disease is far more prominent in females than in males, and the risk of developing SLE is associated with a higher copy number load of TLR7 (Deane et al. 2007; Wang et al. 2014). As a result, TLR7-related CNV may act as a two-edged sword. A high copy number load of TLR7 may guarantee a better protective response to ssRNA viruses, but it may also suggest a poor prognosis for individuals who are at risk of developing SLE. One has to realize, however, that CNV of TLR genes was not selected in nature to foster autoimmune-related disease – its biological role in controlling virus irradication is likely to be more relevant. Therefore, it seems worthwhile to start documenting the types of TLR7 and 8 polymorphisms in different well-defined populations/cohorts that have been affected by COVID-19. Knowledge regarding the mechanisms of disease pathology may be applicable not only in future vaccine development (the constitution and dosage of vaccine components for males versus females) but also with respect to the route by which such a vaccine should be administered (local versus systemic).
References
Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4:499–511. https://doi.org/10.1038/nri1391
Armant MA, Fenton MJ (2002) Toll-like receptors: a family of pattern-recognition receptors in mammals. Genome Biol 3:REVIEWS3011. https://doi.org/10.1186/gb-2002-3-8-reviews3011
Beignon AS et al (2005) Endocytosis of HIV-1 activates plasmacytoid dendritic cells via toll-like receptor-viral RNA interactions. J Clin Invest 115:3265–3275. https://doi.org/10.1172/JCI26032
Chiu RW et al (2004) ACE2 gene polymorphisms do not affect outcome of severe acute respiratory syndrome. Clin Chem 50:1683–1686. https://doi.org/10.1373/clinchem.2004.035436
Deane JA et al (2007) Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity 27:801–810. https://doi.org/10.1016/j.immuni.2007.09.009
Di Domizio J, Blum A, Gallagher-Gambarelli M, Molens JP, Chaperot L, Plumas J (2009) TLR7 stimulation in human plasmacytoid dendritic cells leads to the induction of early IFN-inducible genes in the absence of type I IFN. Blood 114:1794–1802. https://doi.org/10.1182/blood-2009-04-216770
Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C (2004) Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303:1529–1531. https://doi.org/10.1126/science.1093616
Fitzgerald KA, Kagan JC (2020) Toll-like receptors and the control of immunity. Cell 180:1044–1066. https://doi.org/10.1016/j.cell.2020.02.041
Greulich W et al (2019) TLR8 is a sensor of RNase T2 degradation products. Cell 179(1264–1275):e1213. https://doi.org/10.1016/j.cell.2019.11.001
Heil F et al (2004) Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303:1526–1529. https://doi.org/10.1126/science.1093620
Hoffmann M et al (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. https://doi.org/10.1016/j.cell.2020.02.052
Hornung V et al (2002) Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 168:4531–4537. https://doi.org/10.4049/jimmunol.168.9.4531
Kuba K et al (2005) A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med 11:875–879. https://doi.org/10.1038/nm1267
Li Y, Chen M, Cao H, Zhu Y, Zheng J, Zhou H (2013) Extraordinary GU-rich single-strand RNA identified from SARS coronavirus contributes an excessive innate immune response. Microbes Infect 15:88–95. https://doi.org/10.1016/j.micinf.2012.10.008
Lyon MF (1992) Some milestones in the history of X-chromosome inactivation. Annu Rev Genet 26:16–28. https://doi.org/10.1146/annurev.ge.26.120192.000313
Menendez D et al (2019) p53-responsive TLR8 SNP enhances human innate immune response to respiratory syncytial virus. J Clin Invest 129:4875–4884. https://doi.org/10.1172/JCI128626
Parker LC, Prince LR, Sabroe I (2007) Translational mini-review series on Toll-like receptors: networks regulated by Toll-like receptors mediate innate and adaptive immunity. Clin Exp Immunol 147:199–207. https://doi.org/10.1111/j.1365-2249.2006.03203.x
Peiris JS et al (2003) Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 361:1767–1772. https://doi.org/10.1016/s0140-6736(03)13412-5
Plantinga M, Hammad H, Lambrecht BN (2010) Origin and functional specializations of DC subsets in the lung. Eur J Immunol 40:2112–2118. https://doi.org/10.1002/eji.201040562
Porcheddu R, Serra C, Kelvin D, Kelvin N, Rubino S (2020) Similarity in case fatality rates (CFR) of COVID-19/SARS-COV-2 in Italy and China. J Infect Dev Ctries 14:125–128. https://doi.org/10.3855/jidc.12600
Schurz H, Salie M, Tromp G, Hoal EG, Kinnear CJ, Moller M (2019) The X chromosome and sex-specific effects in infectious disease susceptibility. Hum Genomics 13:2. https://doi.org/10.1186/s40246-018-0185-z
Souyris M et al (2018) TLR7 escapes X chromosome inactivation in immune cells. Sci Immunol 3:eaap8855. https://doi.org/10.1126/sciimmunol.aap8855
Tang FS et al (2016) Differential neutrophil activation in viral infections: enhanced TLR-7/8-mediated CXCL8 release in asthma. Respirology 21:172–179. https://doi.org/10.1111/resp.12657
Wang T, Town T, Alexopoulou L, Anderson JF, Fikrig E, Flavell RA (2004) Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 10:1366–1373. https://doi.org/10.1038/nm1140
Wang CM et al (2014) Genetic variations in toll-like receptors (TLRs 3/7/8) are associated with systemic lupus erythematosus in a Taiwanese population. Sci Rep 4:3792. https://doi.org/10.1038/srep03792
Wang T, Du Z, Zhu F, Cao Z, An Y, Gao Y, Jiang B (2020) Comorbidities and multi-organ injuries in the treatment of COVID-19. Lancet 395:e52. https://doi.org/10.1016/S0140-6736(20)30558-4
Wenham C, Smith J, Morgan R, Gender Group C-W (2020) COVID-19: the gendered impacts of the outbreak. Lancet 395:846–848. https://doi.org/10.1016/S0140-6736(20)30526-2
Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA (2012) Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367:1814–1820. https://doi.org/10.1056/NEJMoa1211721
Zhu N et al (2020) A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382:727–733. https://doi.org/10.1056/NEJMoa2001017
Acknowledgements
The authors are grateful to Donna Devine for editorial support.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
de Groot, N.G., Bontrop, R.E. COVID-19 pandemic: is a gender-defined dosage effect responsible for the high mortality rate among males?. Immunogenetics 72, 275–277 (2020). https://doi.org/10.1007/s00251-020-01165-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00251-020-01165-7